CFTR and cystic fibrosis: As it is well accepted that many CFTR mutations show pleiotropic defects [6], and that genotype-to-phenotype predictions in CF are challenging [28], complementary phenotypic assays still provide an easy way to gather early insights into the defects of CFTR variants.